Delphine Saragoussi, MD, MScPH, a physician specialized in public health and social medicine, offers over 15 years of applied experience in epidemiology and pharmacoepidemiology.

Immediately before joining Evidera, Delphine served as a global therapy area lead in the real-world evidence and epidemiology department at Lundbeck where she led psychiatry and neurology research. Prior to employment in the pharmaceutical industry, Delphine worked in academic research units, in semi-private health insurance companies, and in the French Drug Agency with a focus on occupational health, nutrition, genetic epidemiology, and psychiatric epidemiology. During her medical training, Delphine specialized in adult and pediatric endocrinology, genetic disorders, and cardiovascular diseases.

As a result of her diverse experience, Delphine has developed a deep understanding of strategic real-world evidence needs throughout drugs’ development and lifecycle. She has developed and implemented various peri- and post-approval, real-world evidence plans to support successful market access. Her research methods expertise covers the collection of primary data as well as the use of electronic databases (European and U.S. claims and electronic medical records databases). She has experience with burden of illness evaluations, treatment patterns descriptions, PRO validations, and real-world effectiveness studies including the development of proxies for clinical outcomes in administrative databases. Delphine is also well versed in the design of post-authorization safety studies to meet European regulatory and pharmacovigilance evidence needs. Delphine regularly publishes her works in peer-reviewed journals.

Trained in medicine at the University of Paris V Descartes, Delphine also earned a master’s degree in methodology and statistics in biomedical research from the Faculté de Kremlin Bicêtre, University Paris XI. Delphine teaches pharmacoepidemiology at the Paris-V René Descartes University. She is a native French speaker and fluent in English.